Search
for
Sort by
Research 241–270 of 979
- Taurine, a non-proteinous essential amino acid for human body systems: an overview
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Effects of Curcumin and Its Different Formulations in Preclinical and Clinical Studies of Peripheral Neuropathic and Postoperative Pain: A Comprehensive Review
- The protease corin regulates electrolyte homeostasis in eccrine sweat glands
- Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
- Minoxidil restores thymic growth in 22q11.2 deletion syndrome by limiting Sox9+ chondrocyte expansion
- Common Skin Diseases and Metabolic Syndrome: A Proinflammatory Chemokine Perspective
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- MSCs and their exosomes: a rapidly evolving approach in the context of cutaneous wounds therapy
- Inhibition of Cholesterol Biosynthesis Modulates Epithelial-Mesenchymal Transition in Primary Cicatricial Alopecia Through TGFβ and Angiotensin Receptors
- Alopecia Universalis in an Elderly Chinese Man Induced by Sacubitril/Alisartan, a Novel Angiotensin Receptor-Neprilysin Inhibitor
- Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
- Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated?
- Alopecia side-effect of antituberculosis drugs
- Gender Differences in the Regulation of Blood Pressure
- The effect of the combined drug Yuperio with bisoprolol on the dynamics of the heart with dilation of the left chambers, the development of which is due to non-compactness of the myocardium of the left ventricle
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?
- Pathobiology questions raised by telogen effluvium and trichodynia in COVID‐19 patients
- Expression and tissue distribution analysis of Angiotensin II in sheep (Ovis aries) skins associated with white and black coat colors
- The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them?
- Comment on “Androgens and women: COVID‐19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism”
- Angiogenin is expressed in human dermal papilla cells and stimulates hair growth
- Association of ACE2, Insulin Resistance, and Other Parameters in Obese Polycystic Ovary Syndrome Patients Infected with COVID-19
- Androgen receptor transactivity is potentiated by TGF-β1 through Smad3 but checked by its coactivator Hic-5/ARA55 in balding dermal papilla cells
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility
- Probing the Effects of Stress Mediators on the Human Hair Follicle
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells